letter fattyacid oxid in cystic fibrosi the natur of the metabol defect in cystic fibrosi cf is unknown we therefor undertook to studi fattyacid oxid betaoxid in patient with cf there wa no signific differ in the result obtain in control and either affect individu or heterozyg carrier all the valu in the affect individu lay within the normal rang unless for some special reason the defect is not express in leukocyt these result indic that the metabol pathway involv in fattyacid oxid betaoxid is intact in cf it therefor seem unlik that the report defici of certain essenti fatti acid in cf is the result of a defect in fattyacid metabol